≡ YOU ARE HERE HOME » SCIENCE » TECHNOLOGY AREAS GENOMICS The Genomics Platform has a 30-year track record of delivering on transformative projects in the field of genomics. Our goal has been two-fold: to create foundational genomics resources and capabilities for the community, and to undertake large-scale disease-based projects that pioneer approaches and advance the understanding of the genomic basis of disease and other traits. Since the Human Genome Project in the 1990s, the Broad Genomics Platform has played a leadership role in the design, data generation, and methods development in support of major genomic resource projects including: the HapMap the 1000 Genomes Project The Cancer Genome Atlas (TCGA) Comparative Reference Genomes ENCODE the Genotype-tissue Expression Project (GTEx) the Human Microbiome Project the Exome Sequencing Program Center for Mendelian Genomics the Human Cell Atlas (HCA) the Exome Aggregation Consortium (ExAC) and Genome Aggregation Database (gnomAD) projects All Of Us Over the past ten years, The Genomics Platform has been the largest producer of human genomic information in the world. Currently, the group produces approximately 500 terabases of genomic data per month — a rate equivalent to one 30X human whole genome every 10 minutes. The group has processed more than 2 million samples from more than 1,400 groups in more than 50 countries. The Genomics Platform is comprised of approximately 150 people across several functional groups: Alliance and Project Management Analytics, LIMS, and Data Visualization Clinical Research Sequencing Genomic Analysis Lab Operations Research and Development Robotics and Automation Services (fee for service) Walk Up Sequencing The platform provides a range of services — including CAP-accredited and CLIA-certified genomic data generation and advanced genomic analysis — both for the Broad research community and through a fee-for-service model. GENOMICS About History People Facility Whole genome sequencing Whole exome sequencing Whole transcriptome sequencing Clinical research sequencing Data analysis Customized genomic solutions RECENT PUBLICATIONS Loss-of-function mutations in APOC3, triglycerides, and coronary disease. Assessing the clinical utility of cancer genomic and proteomic data across tumor types. Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine. Loss-of-function mutations in SLC30A8 protect against type 2 diabetes. A polygenic burden of rare disruptive mutations in schizophrenia. Other Genomics Publications RELATED GENETIC BASE EDITING TREATS SICKLE CELL DISEASE IN MICE Read More NEWS AT THE BROAD ALL NEWS NEWS / 10.6.21 Richard Merkin, M.D., renews support for transformative science at Broad READ MORE NEWS / 11.15.21 Artificial intelligence–based method predicts risk of atrial fibrillation READ MORE NEWS / 10.28.21 Broad scientists join new consortium studying the function of genetic variation READ MORE NEWS / 10.14.21 Next generation prime editing systems move closer to possible therapeutic applications READ MORE CAREERS GIVING NEWS AND MEDIA CONTACT US PRIVACY POLICY Copyright © 2021 Broad Institute. All rights reserved. TWITTER FACEBOOK YOUTUBE INSTAGRAM